The Role of SBRT in Oligometastatic Patients with Liver Metastases from Breast Cancer

Overview

Journal Rep Pract Oncol Radiother

Specialty Oncology

Date 2017 May 12

PMID 28490988

Citations 8

Authors

Marta Scorsetti

Davide Franceschini

Fiorenza De Rose

Tiziana Comito

Ciro Franzese

Giovanna Masci

Rosalba Torrisi

Luca Vigano

Guido Torzilli

Affiliations

Soon will be listed here.

Abstract

Liver metastases from breast cancer are a common occurrence. Local ablative therapies are a promising therapeutic option for these patients, with the potential for a long term disease control in the setting of "oligometastatic patients". Identification of the perfect candidate for local approaches is still challenging and unclear. Stereotactic body radiation therapy (SBRT) is one of the most valuable local therapy, because of great efficiency, low morbidity and minimal invasiveness. In this paper, we reviewed the state of the art in the care of breast cancer patients with liver metastases, with a focus on SBRT.

Citing Articles

ACROPath Oligometastases: The American College of Radiation Oncology Clinical Pathway.

Jahraus C, Wallner P, Heron D, Crook W, Finkelstein S, Harris A Cureus. 2024; 16(11):e74098.

PMID: 39575357 PMC: 11580758. DOI: 10.7759/cureus.74098.

Clinical Outcomes of Patients with Metastatic Breast Cancer Treated with Hypo-Fractionated Liver Radiotherapy.

Mushonga M, Helou J, Weiss J, Dawson L, Wong R, Hosni A Cancers (Basel). 2023; 15(10).

PMID: 37345175 PMC: 10216793. DOI: 10.3390/cancers15102839.

Stereotactic body radiotherapy (SBRT) for oligo-metastatic liver metastases from breast cancer, as an effective and safe alternative to surgery: a review.

Aoki S, Yamashita H, Abe O, Nakagawa K Transl Cancer Res. 2022; 9(8):5087-5095.

PMID: 35117874 PMC: 8799143. DOI: 10.21037/tcr-20-1833.

Radiomics of Liver Metastases: A Systematic Review.

Fiz F, Vigano L, Gennaro N, Costa G, Bella L, Boichuk A Cancers (Basel). 2020; 12(10).

PMID: 33036490 PMC: 7600822. DOI: 10.3390/cancers12102881.

Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer.

Weykamp F, Konig L, Seidensaal K, Forster T, Hoegen P, Akbaba S Front Oncol. 2020; 10:987.

PMID: 32676455 PMC: 7333735. DOI: 10.3389/fonc.2020.00987.

References

Dellas K . Does Radiotherapy Have Curative Potential in Metastatic Patients? The Concept of Local Therapy in Oligometastatic Breast Cancer. Breast Care (Basel). 2012; 6(5):363-368. PMC: 3357150. DOI: 10.1159/000333115. View

Scheele J, Stangl R, Altendorf-Hofmann A . Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg. 1990; 77(11):1241-6. DOI: 10.1002/bjs.1800771115. View

Saltz L . Metastatic colorectal cancer: is there one standard approach?. Oncology (Williston Park). 2005; 19(9):1147-54. View

Scorsetti M, Franceschini D, De Rose F, Comito T, Villa E, Iftode C . Stereotactic body radiation therapy: A promising chance for oligometastatic breast cancer. Breast. 2016; 26:11-7. DOI: 10.1016/j.breast.2015.12.002. View

Tomlinson J, Jarnagin W, DeMatteo R, Fong Y, Kornprat P, Gonen M . Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007; 25(29):4575-80. DOI: 10.1200/JCO.2007.11.0833. View

Salama J, Hasselle M, Chmura S, Malik R, Mehta N, Yenice K . Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer. 2011; 118(11):2962-70. DOI: 10.1002/cncr.26611. View

Salama J, Chmura S . The role of surgery and ablative radiotherapy in oligometastatic breast cancer. Semin Oncol. 2014; 41(6):790-7. DOI: 10.1053/j.seminoncol.2014.09.016. View

Scorsetti M, Arcangeli S, Tozzi A, Comito T, Alongi F, Navarria P . Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial. Int J Radiat Oncol Biol Phys. 2013; 86(2):336-42. DOI: 10.1016/j.ijrobp.2012.12.021. View

Potters L, Kavanagh B, Galvin J, Hevezi J, Janjan N, Larson D . American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2010; 76(2):326-32. DOI: 10.1016/j.ijrobp.2009.09.042. View

10.

Chang D, Swaminath A, Kozak M, Weintraub J, Koong A, Kim J . Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer. 2011; 117(17):4060-9. DOI: 10.1002/cncr.25997. View

11.

Milano M, Zhang H, Metcalfe S, Muhs A, Okunieff P . Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy. Breast Cancer Res Treat. 2008; 115(3):601-8. DOI: 10.1007/s10549-008-0157-4. View

12.

Hodapp N . [The ICRU Report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT)]. Strahlenther Onkol. 2012; 188(1):97-9. DOI: 10.1007/s00066-011-0015-x. View

13.

Scorsetti M, Clerici E, Comito T . Stereotactic body radiation therapy for liver metastases. J Gastrointest Oncol. 2014; 5(3):190-7. PMC: 4074953. DOI: 10.3978/j.issn.2078-6891.2014.039. View

14.

Milano M, Katz A, Zhang H, Okunieff P . Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. Int J Radiat Oncol Biol Phys. 2011; 83(3):878-86. DOI: 10.1016/j.ijrobp.2011.08.036. View

15.

Comito T, Clerici E, Tozzi A, DAgostino G . Liver metastases and SBRT: A new paradigm?. Rep Pract Oncol Radiother. 2015; 20(6):464-71. PMC: 4661346. DOI: 10.1016/j.rpor.2014.10.002. View

16.

Lee M, Kim J, Dinniwell R, Brierley J, Lockwood G, Wong R . Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol. 2009; 27(10):1585-91. DOI: 10.1200/JCO.2008.20.0600. View

17.

Comito T, Cozzi L, Clerici E, Campisi M, Liardo R, Navarria P . Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach. BMC Cancer. 2014; 14:619. PMC: 4165935. DOI: 10.1186/1471-2407-14-619. View

18.

de Vin T, Engels B, Gevaert T, Storme G, de Ridder M . Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival. Ann Oncol. 2013; 25(2):467-71. DOI: 10.1093/annonc/mdt537. View

19.

Yoon S, Tanabe K . Surgical treatment and other regional treatments for colorectal cancer liver metastases. Oncologist. 1999; 4(3):197-208. View

20.

Hennessey H, Valenti D, Cabrera T, Panet-Raymond V, Roberge D . Cardiac embolization of an implanted fiducial marker for hepatic stereotactic body radiotherapy: a case report. J Med Case Rep. 2009; 3:140. PMC: 2783068. DOI: 10.1186/1752-1947-3-140. View